Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Evotec Se
(OP:
EVOTF
)
7.100
UNCHANGED
Last Price
Updated: 3:59 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Evotec Se
Apple Loses Appeal Over 4G Patent Infringement In London Court, AI Can Drive TSMC's Revenue Rebound, Alibaba Conducts Strategic Review of Youku and Tudou Amidst Rivalry: Today's Top Stories
July 05, 2023
Reuters
Via
Benzinga
Evotec Secures US Government Contract For Orthopoxvirus Antibody
July 05, 2023
The U.S.
Via
Benzinga
Adapsyn Bioscience Inks Collaboration Pact With Evotec
September 21, 2022
Via
Benzinga
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
July 06, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Why Are Evotec Shares Trading Lower On Friday?
February 04, 2022
Bayer AG (OTC: BAYRY) has
Via
Benzinga
Germany Based Evotec Sets Terms For $576M US IPO
October 27, 2021
German biotech Evotec SE (OTC: EVTCY) plans to raise $576 million by offering 22 million ADSs at $26.16. At the proposed price, Evotec would command a market value of $...
Via
Benzinga
Pasithea, Evotec Ink Drug Development Pact
October 11, 2021
Pasithea Therapeutics Corp (NASDAQ: KTTA) has initiated a new chemical entity development program and named Evotec SE (OTC: EVOTF) its research...
Via
Benzinga
Evotec Expands Neuroscience Collaboration with Bristol Myers
October 08, 2021
Bristol Myers Squibb & Co (NYSE: BMY) has expanded its neuroscience collaboration with Evotec SE (OTC: EVTCY) to include a new cell type. Related:...
Via
Benzinga
Bristol Myers Exercises Option In-License Evotec's Neurodegenerative Candidate
September 02, 2021
Evotec SE (OTC: EVTCY) says that Bristol Myers Squibb Co (NYSE: BMY) has exercised its option to enter into an exclusive global license for EVT8683. It...
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.